Avacta Group Plc
Status: Publicly traded
Direct answer
Avacta Group Plc is publicly traded on LSE under the ticker AVCT.L.
Avacta Group Plc operates as a clinical-stage biopharmaceutical company, specializing in the development of cancer therapies and diagnostic solutions. These advancements are driven by its proprietary Affimer and pre|CISION technology platforms, with the company's activities spanning the United Kingdom, North America, South Korea, and broader regions of Asia and Europe. Functioning across distinct Diagnostics and...
Can you invest in Avacta Group Plc?
Yes. Avacta Group Plc trades publicly on LSE as AVCT.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Avacta Group Plc
Detailed equity research is provided by MarketSnap.